TSX News -
VBI Vaccines Completes Enrollment of Participants in the Phase I Clinical Trial of Its Preventative Cytomegalovirus Vaccine Candidate
CAMBRIDGE, MASSACHUSETTS–(Marketwired – Sept. 20, 2016) – VBI Vaccines Inc. (NASDAQ:VBIV)(TSX:VBV) (“VBI”) today announced that it has completed enrollment and […]